Active Ingredient(s): Lomitapide Medylate
FDA Approved: * December 21, 2012
Category: Cholesterol

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Juxtapid Overview

Lomitapide , sold under the brand name Juxtapid in the US and as Lojuxta in the EU) is a medication used as a lipid-lowering agent for the treatment of familial hypercholesterolemia, developed by Aegerion Pharmaceuticals.[3] It has been tested in clinical trials as single treatment and in combinations with atorvastatin, ezetimibe and fenofibrate.[4][5] The US Food and Drug Administration (FDA) approved lomitapide on 21 December 2012, as an orph...

Read more Juxtapid Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Lomitapide

Recent Juxtapid Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Lomitapide Medylate
  • Capsule: 10mg, 20mg, 30mg, 40mg, 5mg, 60mg
  • Capsule, Hard Gelatin: 5 mg, 10 mg, and 20 mg.
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Juxtapid: (6 results)

Sorted by National Drug Code
  • 76431-105 Juxtapid 5 mg Oral Capsule by Aegerion Pharmaceuticals, Inc.
  • 76431-110 Juxtapid 10 mg Oral Capsule by Aegerion Pharmaceuticals, Inc.
  • 76431-120 Juxtapid 20 mg Oral Capsule by Aegerion Pharmaceuticals, Inc.
  • 76431-130 Juxtapid 30 mg Oral Capsule by Aegerion Pharmaceuticals, Inc.
  • 76431-140 Juxtapid 40 mg Oral Capsule by Aegerion Pharmaceuticals, Inc.
  • 76431-160 Juxtapid 60 mg Oral Capsule by Aegerion Pharmaceuticals, Inc.

Other drugs which contain Lomitapide Medylate or a similar ingredient: (1 result)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 15 June 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA